Department of Experimental and Translational Ophthalmology, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany.
Int J Mol Sci. 2024 Jan 28;25(3):1624. doi: 10.3390/ijms25031624.
Age-related macular degeneration (AMD) is a severe retinal disease that causes irreversible visual loss and blindness in elderly populations worldwide. The pathological mechanism of AMD is complex, involving the interactions of multiple environmental and genetic factors. A poor understanding of the disease leads to limited treatment options and few effective prevention methods. The discovery of autoantibodies in AMD patients provides an opportunity to explore the pathogenesis and treatment direction of the disease. This review focuses on the mitochondria-associated autoantibodies and summarizes the functional roles of mitochondria under physiological conditions and their alterations during the pathological states. Additionally, it discusses the crosstalk between mitochondria and other organelles, as well as the mitochondria-related therapeutic strategies in AMD.
年龄相关性黄斑变性(AMD)是一种严重的视网膜疾病,可导致全球老年人群体的视力不可逆转地丧失和失明。AMD 的病理机制复杂,涉及多种环境和遗传因素的相互作用。对该疾病的认识不足导致治疗选择有限,有效的预防方法也很少。AMD 患者自身抗体的发现为探索该疾病的发病机制和治疗方向提供了机会。本综述重点关注与线粒体相关的自身抗体,并总结了线粒体在生理条件下的功能作用及其在病理状态下的改变。此外,还讨论了线粒体与其他细胞器之间的相互作用以及 AMD 中的线粒体相关治疗策略。